Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ventyx Biosciences, Inc.

2.46
+0.21009.33%
Post-market: 2.40-0.0600-2.44%19:37 EDT
Volume:3.52M
Turnover:8.33M
Market Cap:175.06M
PE:-1.40
High:2.47
Open:2.23
Low:2.23
Close:2.25
Loading ...
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 16, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Correspondence

Form CORRESP - Correspondence
Apr 05, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 13, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]